Article
NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process
26 May 2022
Abstract excerpt
Reversing chemotherapy resistance in small cell lung cancer (SCLC) is crucial to improve patient prognosis. The present study aims to investigate the underlying mechanisms in SCLC chemoresistance. We see that nuclear receptor binding factor 2 (NRBF2) is a poor prognostic factor in SCLC. The effects of NRBF2 on chemoresistance were determined in SCLC. The underlying molecular mechanisms of NRBF2 in the autophagy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
